Jung Yoon Kang

Jung Yoon Kang

Auto-generated profile, based on publicly available information

Jung Yoon Kang

Department of Urology, Nowon Eulji Medical Center, Eulji University School of Medicine, Seoul, Republic of Korea

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2020 in Journal of Laparoendoscopic & Advanced Surgical Techniques
Verified
Journal Article
Closed access
JCJae Duck Choi
Jae Duck Choi
TYTag keun Yoo
Tag keun Yoo
JKJung Yoon Kang
Jung Yoon Kang
KMKyong Tae Moon
Kyong Tae Moon
JKJung Hoon Kim
Jung Hoon Kim
JCJeoung Man Cho
Jeoung Man Cho
Background: Percutaneous aspiration with sclerotherapy (PAS) and laparoscopic marsupialization (LM) are minimally invasive treatment modalities for renal cysts. We aimed to compare the efficacy and cost/effectiveness of LM and PAS for the treatment of simple symptomatic renal cysts. Methods: Data were prospectively collected from three health care institutions in which 80 patients with symptomatic simple renal cysts underwent a single session of PAS with 95% ethanol (PAS group, n = 40) or underwent LM under general anesthesia (LM group, n = 40) between March 2012 and May 2016. We compared the patient profile, duration of procedure, duration of hospital stay, radiological and symptomatic success rates, treatment costs, and incidence of complications between the two groups. Results: At the 6-month follow-up, the radiological success rate in the LM group was significantly greater than that in the PAS group (97.5% versus 60%; P < .001). The symptomatic success rate was comparable in the two groups (95% versus 90%; P = .675). The treatment failure rate did not significantly differ between the two groups (5.0% versus 17.5%, P = .154). The mean total cost in the PAS and LM groups was 1256 USD and 2343 USD, respectively ( P = .001). No significant between-group difference was noted regarding the overall complication rate ( P = .615). Conclusions: Both LM and PAS are effective and safe procedures for the treatment of symptomatic simple renal cysts. A single session of PAS seems to be a cost-effective method for the management of symptomatic simple renal cysts.

21 September 2021 in International Urology and Nephrology
Verified
Journal Article
Closed access
PDF file
JLJun Ho Lee
Jun Ho Lee
TYTag keun Yoo
Tag keun Yoo
JKJung Yoon Kang
Jung Yoon Kang
JCJeong Man Cho
Jeong Man Cho
YPYeon Won Park
Yeon Won Park
JCJae Duck Choi
Jae Duck Choi

1 December 2014 in Prostate International
Verified
Journal Article
Open access
PDF file
HCHee Ju Cho
Hee Ju Cho
SSSoon Cheol Shin
Soon Cheol Shin
JCJeong Man Cho
Jeong Man Cho
JKJung Yoon Kang
Jung Yoon Kang
TYTag keun Yoo
Tag keun Yoo
The aim of this study was to define the clinical significance of transurethral resection of the prostate (TURP) in patients with benign prostate hyperplasia (BPH) and an elevated prostate-specific antigen (PSA) level. We retrospectively evaluated patients with BPH, lower urinary tract symptoms (LUTS; International Prostate Symptom Score [IPSS]≥8), an elevated serum PSA level (≥4 ng/mL), and previous negative transrectal ultrasonography (TRUS) guided prostate biopsy. The PSA level after TURP was monitored by long-term follow-up. The tumor detection rate on resected prostate tissue, IPSS, maximal urinary flow rate (Qmax), and postvoid residual urine (PVR) were analyzed. One-hundred and eighty-six patients were enrolled. Histological examination of resected tissue by TURP revealed prostate cancer in 12 of these patients (6.5%). Among 174 patients without prostate cancer, the mean PSA level and the PSA normalization rate in 112 patients followed up at postoperative day (POD) 3 months were 1.26±0.13 ng/mL and 94.6%, respectively. The mean PSA level and the PSA normalization rate were 1.28±1.01 ng/mL and 95.7% in 47 patients at 1st year, 1.17±0.82 ng/mL and 97.1% in 34 patients at second years, and 1.34±1.44 ng/mL and 97.2% in 36 patients at third years of TURP. One patient showed a dramatic increase in the PSA level was diagnosed with prostate cancer at 7 years after TURP. IPSS, quality of life, Qmax, and PVR were improved significantly at POD 3 months compared to baseline (P<0.05), respectively. TURP significantly reduced the serum PSA level, which was maintained for at least 3 years. This could be helpful to screen the prostate cancer using PSA value in the patient with previous negative biopsy and elevated PSA. In addition, TURP improves IPSS, Qmax, and PVR in patients with BPH, moderate LUTS, and an elevated PSA level.

1 January 2015 in Korean Journal of Urology
Verified
Journal Article
Open access
PDF file
SLSeung Hwan Lee
Seung Hwan Lee
JCJeoung Man Cho
Jeoung Man Cho
HCHee Ju Cho
Hee Ju Cho
JKJung Yoon Kang
Jung Yoon Kang
EKEun Kyung Kim
Eun Kyung Kim
TYTag keun Yoo
Tag keun Yoo
Lee SW, et al. Korean J Urol. 2015 Jul;56(7):505-514. https://doi.org/10.4111/kju.2015.56.7.505

1 January 2015 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
HSHwancheol Son
Hwancheol Son
JPJuhyun Park
Juhyun Park
SSSang Hoon Song
Sang Hoon Song
JKJung Yoon Kang
Jung Yoon Kang
SHSung Kyu Hong
Sung Kyu Hong
KLKyung Seop Lee
Kyung Seop Lee
Son H, et al. J Korean Med Sci. 2015 Feb;30(2):180-185. https://doi.org/10.3346/jkms.2015.30.2.180

1 January 2015 in Korean Journal of Urology
Verified
Journal Article
Open access
PDF file
JKJung Yoon Kang
Jung Yoon Kang
Kang JY. Korean J Urol. 2015 Apr;56(4):255-256. http://dx.doi.org/10.4111/kju.2015.56.4.255